The number of tumour-infiltrating lymphocytes increased per tumour weight after anti-PD-1 antibody administration (Control; 1.7 ± 0.7 × 105 /g, 4H2; 3.6 ± 0.8 × 105 /g. The gene discussed is PDCD1; the disease is neoplasm.